Naujausios naujienos ir straipsniai apie genetinius tyrimus
May 4, 2026
Researchers from Chiba University have made a breakthrough in developing a new treatment for refractory skin cancer using targeted alpha therapy. This innovative approach has shown promising results in treating patients with aggressive and resistant skin cancers.
May 4, 2026
A recent study has found that the incidence of several early-onset cancers increased between 2010 and 2019. The rise in these cancers, which occur before the age of 50, highlights a growing concern for public health.
May 4, 2026
A recent analysis of cancer incidence rates indicates a significant increase in several early-onset cancers between 2010 and 2019. The study suggests that younger individuals are developing certain types of cancer at higher frequencies.
May 3, 2026
American Heart Association. "Micro-nano-plastics found in artery-clogging plaque in the neck." ScienceDaily. ScienceDaily, 23 April 2025. <www.sciencedaily.com/releases/2025/04/250423112651.htm>...
May 3, 2026
Scripps Research Institute. "Enzyme engineering opens door to novel therapies for Parkinson's, cancers and other hard-to-target protein diseases." ScienceDaily. ScienceDaily, 27 March 2025. <www.sc...
May 3, 2026
Researchers at the Scripps Research Institute have made significant advancements in enzyme engineering, paving the way for novel therapies to treat complex protein-related diseases such as Parkinson's and certain cancers.
May 3, 2026
Researchers at NYU Langone Health have developed a gene-based blood test that may be able to detect early signs of melanoma recurrence. This non-invasive test has shown promise in identifying patients who are at risk of cancer returning.
May 3, 2026
Researchers have developed a gene-based blood test that may help detect early signs of melanoma recurrence. This non-invasive test has shown promise in identifying patients at risk of cancer return.
May 3, 2026
Researchers have developed a gene-based blood test that may help identify early signs of melanoma recurrence. The test uses genetic information to detect cancer cells in the bloodstream, potentially improving patient outcomes.
